insights_auto
Hvorfor har 207940 gått opp? 9,94%?
Gå mer i dybdenchevron_right
207940:KRX
Samsung Biologics Co Ltd
1 427 000,00 KRW
arrow_upward
+9,94%(+129 000,00) 1 D
19. okt., 15:32:30 GMT+9 · KRW
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for 207940 …
Åpne
1 290 000 KRW
Høy
1 432 000 KRW
Lav
1 269 000 KRW
Markedsverdi
69,30 bill.
Snittvolum
49,67k
Volum
151,20k
P/E-forhold
31,09
52 u høy
1 973 600 KRW
52 u lav
1 110 460 KRW
EPS
45 897 KRW
Utestående aksjer
46,29 mill.
Antall ansatte
5k
Åpne
1 290 000 KRW
Høy
1 432 000 KRW
Lav
1 269 000 KRW
Markedsverdi
69,30 bill.
Snittvolum
49,67k
Volum
151,20k
P/E-forhold
31,09
52 u høy
1 973 600 KRW
52 u lav
1 110 460 KRW
EPS
45 897 KRW
Utestående aksjer
46,29 mill.
Antall ansatte
5k
Nyhetssaker
Fra nettkilder og nyhetspartnere
ad-hoc-news.de
·
for 15 timer siden
Samsung Biologics clears 87.88% tender hurdle: what it means for Samsung Biologics stock
파이낸셜뉴스
·
for 15 timer siden
Samsung Biologics rises for third straight session amid market slump, rebounds 11% [Stock NOW]
Profil
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines.
The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol-Myers Squibb. Wikipedia
Om Samsung Biologics Co Ltd
Administrerende direktørJohn Rim
Ansatte5,33k
Grunnlagt2011
Hovedkontor-
Sektor-
Nettstedsamsungbiologics.com